SELARSDI is approved for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis in adults and ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...

Biosimilars have also made inroads among generic suppliers. But development is lengthy and expensive. McKinsey estimates that it costs $100 to $300 million to develop a biosimilar and that it takes ...

3, 4 It is refreshing to see the debate over the delivery of adrenaline move forward a stage, with the subcutaneous route no longer recommended ... of intramuscular adrenaline at a dose of 0.5 ml of 1 ...

Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...

Trulicity (dulaglutide) is a prescription drug that can cause weight loss in some people but is not approved for this use.

Tremfya was administered subcutaneously for both induction and maintenance, inducing a clinical response in 65% of moderate ...

1. Vasodilation - increases surface blood flow, increases heat loss (when ambient temperature is less that body temperature). Maximal vasodilation can increase cutaneous blood flow to 3000 ml/minute ...

It is important to understand the differences between risk-based decision making and other decision making in a pharmaceutical quality system.

Mobile Legends: Bang Bang is an amazing MOBA for mobile, which can be compared with some of the bigger names out there, like League of Legends: Wild Rift. Similarly, Mobile Legends has tons of ...